Study of Crizotinib for ROS1 and MET Activated Lung Cancer
Condition(s):Non-squamous Non-small-cell Lung Cancer; Stage IV Non-small Cell Lung Cancer; ROS1 Gene Rearrangement; MET Activating Mutation; MET AmplificationLast Updated:June 18, 2023Recruiting